Showing results (171-180 of 179) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 179 results.
The European Respiratory Journal|March 25, 2014
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statementChristoph Lange, Ibrahim Abubakar, Jan-Willem C Alffenaar, et al.
The European Respiratory Journal|April 15, 2016
Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBSimon Tiberi, Giovanni Sotgiu, Lia D'Ambrosio, et al.
The Lancet Regional Health. Europe|December 16, 2025
Correction to Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study Lancet Reg Health Eur 57 (2025) 101416 LLRHEUROPE-D-25-00310Martina Sester, Neus Altet-Gomez, Åse Bengaard Andersen, et al.
The Lancet Regional Health. Europe|August 18, 2025
Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet studyMartina Sester, Neus Altet-Gomez, Åse Bengaard Andersen, et al.
The European Respiratory Journal|March 21, 2015
Towards tuberculosis elimination: an action framework for low-incidence countriesKnut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, et al.
The European Respiratory Journal|September 26, 2015
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countriesHaileyesus Getahun, Alberto Matteelli, Ibrahim Abubakar, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 7, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility studyOnno Akkerman, Alena Aleksa, Jan-Willem Alffenaar, et al.
The European Respiratory Journal|October 12, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global reportSergey Borisov, Edvardas Danila, Andrei Maryandyshev, et al.
The European Respiratory Journal|October 12, 2023
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort, Nicolas Casco, Alberto Levi Jorge, et al.
Pageof 18